(CNN) — The U.S Food and Drug Administration has approved a new cholesterol-lowering medication.
Esperion says they’ve created a once a day tablet called Nexletol. According to the company, the drug is an alternative to statins.
The company says it’s the first oral non-statin drug approved in nearly two decades. And studies show the dug reduced cholesterol by an average of 18 percent when used with moderate or high-intensity statins.
The drug could be available as early as late March according to Esperion.